Complacency a key concern as HIV epidemic persists in Africa
Complacency a concern as AIDS treatment improves in Africa but youth infection rates high
One major challenge facing Hahn is the teen vaping epidemic
[The Conversation Africa] The infectious disease burden in Africa is very high, particularly for tuberculosis (TB), malaria and HIV/AIDS. In 2018, nearly a quarter (24%) of TB cases in the world were in Africa. The region accounted for 93% of malaria cases. The continent also bears the brunt of the HIV epidemic: 20.6 million of the 37.9 million people living with HIV are in eastern and southern Africa.
Advocacy groups are urging Facebook to remove advertisements that they say unfairly infer that the HIV/AIDS prevention Truvada PrEP (pre-exposure prophylaxis) is dangerous, an allegation they say could endanger the people who are most at risk of contracting the disease. More than 50 HIV/AIDs, LGBTQ and public health advocacy groups released a letter on Monday asking Facebook and Instagram to remove the ads from their platforms. The ads referred specifically to “Truvada PrEP” (the brand name for one of the medications, dtenofovir disoproxil fumarate, used as PrEP) and in some cases more generically to “PrE...
[New Era] Ongwediva -Israel Hatutale, who has been living with the HIV virus for the past 21 years, says the fight against the deadly epidemic can only be a success with the involvement of men.
[New Times] The United Nations Programme for HIV/AIDS (UNAIDS) target of ending the AIDS epidemic by 2030 will remain a mirage if children and young people are not given access to Anti-retro viral treatment, medics have said.
PMID: 31800273 [PubMed - in process]
[WHO] Growing resistance to HIV drugs in Africa is threatening the significant progress made in the global fight against the virus. In an effort to reinforce the gains and end the AIDS epidemic by 2030, the World Health Organization (WHO) and partners today are unveiling a five-year plan to monitor, prevent and respond to drug resistance.
[Daily Maverick] In the shadow of HIV many things are hidden. Do a quick Google search ('in the shadow of HIV') and a torrent of disease and social ills will blast across your browser. You'll find gender-based violence and stigma, sugar-daddies, obesity and hypertension, patriarchy, cancer and diabetes, denial, guilt, and the opioid crisis. Also hiding, deep in the shadows, are adolescent boys and young men.
UN teams are on the ground in Samoa as the country combats a deadly measles epidemic. So far, there have been more than 4,200 cases and 62 deaths, mainly babies, prompting authorities to declare a state of emergency on 15 November and launch a mass vaccination campaign five days later.
Purpose of review The purpose of this review is to summarize the current standards of care for both HIV treatment and HIV prevention in 2019. Recent findings Current HIV treatment is started as soon as feasible in a person with HIV infection and consists of a three-drug oral daily antiretroviral regimen, consisting of two nucleoside analogue reverse transcriptase inhibitors combined with a third drug, either an integrase inhibitor, a non-nucleoside reverse transcriptase inhibitor, or a protease inhibitor. Present treatment regimens are potent, convenient, generally well tolerated and durable, and lead to a normal life...